Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
- 20 July 2012
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (9) , 1841-1848
- https://doi.org/10.1111/j.1538-7836.2012.04859.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor DabigatranStroke, 2011
- Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine modelBritish Journal of Anaesthesia, 2010
- Prothrombin Complex Concentrate (Beriplex® P/N)Drugs, 2009
- Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospitalCritical Care, 2008
- Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agentsBlood, 2008
- Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trialJournal of Thrombosis and Haemostasis, 2008
- Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosisJournal of Thrombosis and Haemostasis, 2007
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateThrombosis and Haemostasis, 2007
- Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteersThrombosis and Haemostasis, 2007